VIZGENYX
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Nov 2026)
What this means for you
This application is over — abandoned 02 Nov 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97463163
- Mark type
- Word mark
- Filed
- 17 Jun 2022
- Published for opposition
- 08 Aug 2023
- Abandoned
- 02 Nov 2026
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines
Owner
- JOHNSON & JOHNSON, New Brunswick, NJ, US
- JOHNSON & JOHNSON, New Brunswick, NJ, US
Prosecution history
- 02 Nov 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Nov 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Aug 2026 — SOU EXTENSION 5 GRANTED
- 30 Mar 2026 — SOU EXTENSION 5 FILED
- 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 4 GRANTED
- 18 Sept 2025 — SOU EXTENSION 4 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 3 GRANTED
- 27 Mar 2025 — SOU EXTENSION 3 FILED
- 27 Mar 2025 — SOU TEAS EXTENSION RECEIVED